BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31744257)

  • 1.
    de Almeida BC; Dos Anjos LG; Uno M; Cunha IWD; Soares FA; Baiocchi G; Baracat EC; Carvalho KC
    Cells; 2019 Nov; 8(11):. PubMed ID: 31744257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNAs in uterine sarcomas and mixed epithelial-mesenchymal uterine tumors: a preliminary report.
    Kowalewska M; Bakula-Zalewska E; Chechlinska M; Goryca K; Nasierowska-Guttmejer A; Danska-Bidzinska A; Bidzinski M
    Tumour Biol; 2013 Aug; 34(4):2153-60. PubMed ID: 23558962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
    Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer.
    Schubert M; Spahn M; Kneitz S; Scholz CJ; Joniau S; Stroebel P; Riedmiller H; Kneitz B
    PLoS One; 2013; 8(6):e65064. PubMed ID: 23798998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 expression and other clinicopathologic parameters in uterine leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    Wien Klin Wochenschr; 2004 Feb; 116(4):135-9. PubMed ID: 15038405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leiomyosarcoma: One disease or distinct biologic entities based on site of origin?
    Worhunsky DJ; Gupta M; Gholami S; Tran TB; Ganjoo KN; van de Rijn M; Visser BC; Norton JA; Poultsides GA
    J Surg Oncol; 2015 Jun; 111(7):808-12. PubMed ID: 25920434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of fibroblast growth factor 2 in patients with uterine smooth muscle tumors: an immunohistochemical study.
    Bodner-Adler B; Mayerhofer K; Czerwenka K; Kimberger O; Koelbl H; Bodner K
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():62-67. PubMed ID: 27825029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.
    Edris B; Espinosa I; Mühlenberg T; Mikels A; Lee CH; Steigen SE; Zhu S; Montgomery KD; Lazar AJ; Lev D; Fletcher JA; Beck AH; West RB; Nusse R; van de Rijn M
    J Pathol; 2012 Jun; 227(2):223-33. PubMed ID: 22294416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinoma.
    Tang Z; Ow GS; Thiery JP; Ivshina AV; Kuznetsov VA
    Int J Cancer; 2014 Jan; 134(2):306-18. PubMed ID: 23825028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential diagnostic biomarkers: differential expression of LMP2/β1i and cyclin B1 in human uterine leiomyosarcoma.
    Hayashi T; Horiuchi A; Sano K; Hiraoka N; Ichimura T; Sudo T; Ishiko O; Yaegashi N; Aburatani H; Konishi I
    Tumori; 2014; 100(4):99e-106e. PubMed ID: 25296613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Lymphadenectomy Improve Survival in Uterine Leiomyosarcoma?
    Tasci T; Karalok A; Taskin S; Ureyen I; Kımyon G; Tulek F; Ozfuttu A; Turan T; Tulunay G; Kose MF; Ortac F
    Int J Gynecol Cancer; 2015 Jul; 25(6):1031-6. PubMed ID: 25853382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma.
    Fedorko M; Juracek J; Stanik M; Svoboda M; Poprach A; Buchler T; Pacik D; Dolezel J; Slaby O
    Biochem Med (Zagreb); 2017 Jun; 27(2):411-417. PubMed ID: 28694731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor as a prognostic biomarker and therapeutic target in uterine leiomyosarcoma.
    Baek MH; Park JY; Park Y; Kim KR; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    J Gynecol Oncol; 2018 May; 29(3):e30. PubMed ID: 29533018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of von Willebrand factor, CD34, CD31, and vascular endothelial growth factor expression in women with uterine leiomyosarcomas.
    Poncelet C; Fauvet R; Feldmann G; Walker F; Madelenat P; Darai E
    J Surg Oncol; 2004 May; 86(2):84-90. PubMed ID: 15112250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma.
    Park JY; Park SK; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2011 Aug; 122(2):255-9. PubMed ID: 21565389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating microRNAs as potential biomarkers for endometriosis.
    Cho S; Mutlu L; Grechukhina O; Taylor HS
    Fertil Steril; 2015 May; 103(5):1252-60.e1. PubMed ID: 25772772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages.
    Rovirosa A; Ascaso C; Ordi J; Abellana R; Arenas M; Lejarcegui JA; Pahisa J; Puig-Tintoré LM; Mellado B; Armenteros B; Iglesias X; Biete A
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1320-9. PubMed ID: 11955745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and subclinical endometritis induced alterations in bovine endometrial transcriptome and miRNome profile.
    Salilew-Wondim D; Ibrahim S; Gebremedhn S; Tesfaye D; Heppelmann M; Bollwein H; Pfarrer C; Tholen E; Neuhoff C; Schellander K; Hoelker M
    BMC Genomics; 2016 Mar; 17():218. PubMed ID: 26965375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?
    Gonzalez Dos Anjos L; de Almeida BC; Gomes de Almeida T; Mourão Lavorato Rocha A; De Nardo Maffazioli G; Soares FA; Werneck da Cunha I; Baracat EC; Carvalho KC
    Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30200635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma.
    Zivanovic O; Jacks LM; Iasonos A; Leitao MM; Soslow RA; Veras E; Chi DS; Abu-Rustum NR; Barakat RR; Brennan MF; Hensley ML
    Cancer; 2012 Feb; 118(3):660-9. PubMed ID: 21751199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.